Depletion of SIRT6 sensitized pancreatic cancer cells to gemcitabine (26), and hepatocellular carcinoma cells to chemotherapeutic agents via downregulation of MDR1 expression (43). The gene discussed is SIRT6; the disease is hepatocellular carcinoma.